Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P61278 (
somatostatin
)
22,083
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Amphiphysins are SH3 domain-containing proteins thought to function in clathrin-mediated endocytosis. To investigate the potential role of
amphiphysin II
in cellular trafficking of G protein-coupled
somatostatin
(SRIF) receptors, we generated an AtT-20 cell line stably overexpressing
amphiphysin IIb
, a splice variant that does not bind clathrin. Endocytosis of (125)I-[d-Trp(8)]SRIF was not affected by
amphiphysin IIb
overexpression. However, the maximal binding capacity (B(max)) of the ligand on intact cells was significantly lower in
amphiphysin IIb
overexpressing than in non-transfected cells. This difference was no longer apparent when the experiments were performed on crude cell homogenates, suggesting that
amphiphysin IIb
overexpression interferes with SRIF receptor targeting to the cell surface and not with receptor synthesis. Accordingly, immunofluorescence experiments demonstrated that, in amphiphysin overexpressing cells, sst(2A) and sst(5) receptors were segregated in a juxtanuclear compartment identified as the trans-Golgi network. Amphiphysin IIb overexpression had no effect on corticotrophin-releasing factor 41-stimulated adrenocorticotropic hormone secretion, suggesting that it is not involved in the regulated secretory pathway. Taken together, these results suggest that
amphiphysin II
is not necessary for SRIF receptor endocytosis but is critical for its constitutive targeting to the plasma membrane. Therefore,
amphiphysin IIb
may be an important component of the constitutive secretory pathway.
...
PMID:Role of amphiphysin II in somatostatin receptor trafficking in neuroendocrine cells. 1466 May 76